Page last updated: 2024-11-03

procarbazine and Coronary Disease

procarbazine has been researched along with Coronary Disease in 2 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baĭsogolov, GD1
Shishkin, IP1
Zeymer, U1
Hirschmann, WD1
Neuhaus, KL1

Other Studies

2 other studies available for procarbazine and Coronary Disease

ArticleYear
[Myocardial infarct, acute coronary insufficiency and sudden death in lymphogranulomatosis patients after irradiation of the mediastinum].
    Radiobiologia, radiotherapia, 1983, Volume: 24, Issue:2

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Coronary Disease; Cyclophospha

1983
Left main coronary stenosis by a mediastinal lymphoma.
    The Clinical investigator, 1992, Volume: 70, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Coronary Disease; Cyclophosphamide; Humans; Lymphoma

1992